Joel G. Ray
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Joel G. Ray has a total of 75 co-authors. Here are the top co-authors by number of shared publications:
Marian J. Vermeulen
Department of Medicine, Schulich School of Medicine and Dentistry, London Health Sciences Center, University of Western Ontario, London, Ontario (Ying)
5 shared publications- Michael J. Schull
ICES
4 shared publications Philip R. Wyatt
3 shared publicationsChris Meier
2 shared publicationsDavid E. C. Cole
2 shared publicationsDonald A Redelmeier
Department of Medicine, University of Toronto, Toronto, Ontario, Canada
2 shared publications
Latest Publications
- 1 January 2011
- Published by Wolters Kluwer Health in Epidemiology
- Vol. 22 (1) , 129-130
Nonalcoholic Fatty Liver Disease and Acute Ischemic Stroke
- 1 January 2011
- Published by Wolters Kluwer Health in Epidemiology
- Vol. 22 (1) , 129-130
Nonalcoholic Fatty Liver Disease and Acute Ischemic Stroke
- Open Access
- 7 September 2010
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 7 (9) , e1000337
Major Radiodiagnostic Imaging in Pregnancy and the Risk of Childhood Malignancy: A Population-Based Cohort Study in Ontario
The association between fetal exposure to major radiodiagnostic testing in pregnancy—computed tomography (CT) and radionuclide imaging—and the risk of childhood cancer is not established. We completed a population-based study of 1.8 million maternal-child pairs in the province of Ontario, from 1991 to 2008. We used Ontario's universal health care–linked administrative databases to identify all term obstetrical deliveries and newborn records, inpatient and outpatient major radiodiagnostic services, as well as all children with a malignancy after birth. There were 5,590 mothers exposed to major radiodiagnostic testing in pregnancy (3.0 per 1,000) and 1,829,927 mothers not exposed. The rate of radiodiagnostic testing increased from 1.1 to 6.3 per 1,000 pregnancies over the study period; about 73% of tests were CT scans. After a median duration of follow-up of 8.9 years, four childhood cancers arose in the exposed group (1.13 per 10,000 person-years) and 2,539 cancers in the unexposed group (1.56 per 10,000 person-years), a crude hazard ratio of 0.69 (95% confidence interval 0.26–1.82). After adjusting for maternal age, income quintile, urban status, and maternal cancer, as well as infant sex, chromosomal or congenital anomalies, and major radiodiagnostic test exposure after birth, the risk was essentially unchanged (hazard ratio 0.68, 95% confidence interval 0.25–1.80). Although major radiodiagnostic testing is now performed in about 1 in 160 pregnancies in Ontario, the absolute annual risk of childhood malignancy following exposure in utero remains about 1 in 10,000. Since the upper confidence limit of the relative risk of malignancy may be as high as 1.8 times that of an unexposed pregnancy, we cannot exclude the possibility that fetal exposure to CT or radionuclide imaging is carcinogenic. Please see later in the article for the Editors' Summary
- 7 September 2010
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 7 (9) , e1000337
Open AccessMajor Radiodiagnostic Imaging in Pregnancy and the Risk of Childhood Malignancy: A Population-Based Cohort Study in Ontario
The association between fetal exposure to major radiodiagnostic testing in pregnancy—computed tomography (CT) and radionuclide imaging—and the risk of childhood cancer is not established. We completed a population-based study of 1.8 million maternal-child pairs in the province of Ontario, from 1991 to 2008. We used Ontario's universal health care–linked administrative databases to identify all term obstetrical deliveries and newborn records, inpatient and outpatient major radiodiagnostic services, as well as all children with a malignancy after birth. There were 5,590 mothers exposed to major radiodiagnostic testing in pregnancy (3.0 per 1,000) and 1,829,927 mothers not exposed. The rate of radiodiagnostic testing increased from 1.1 to 6.3 per 1,000 pregnancies over the study period; about 73% of tests were CT scans. After a median duration of follow-up of 8.9 years, four childhood cancers arose in the exposed group (1.13 per 10,000 person-years) and 2,539 cancers in the unexposed group (1.56 per 10,000 person-years), a crude hazard ratio of 0.69 (95% confidence interval 0.26–1.82). After adjusting for maternal age, income quintile, urban status, and maternal cancer, as well as infant sex, chromosomal or congenital anomalies, and major radiodiagnostic test exposure after birth, the risk was essentially unchanged (hazard ratio 0.68, 95% confidence interval 0.25–1.80). Although major radiodiagnostic testing is now performed in about 1 in 160 pregnancies in Ontario, the absolute annual risk of childhood malignancy following exposure in utero remains about 1 in 10,000. Since the upper confidence limit of the relative risk of malignancy may be as high as 1.8 times that of an unexposed pregnancy, we cannot exclude the possibility that fetal exposure to CT or radionuclide imaging is carcinogenic. Please see later in the article for the Editors' Summary
- 1 September 2010
- Vol. 132, 251-5
Gestational prediabetes: a new term for early prevention?
Women with gestational diabetes mellitus (GDM) have higher rates of foetal macrosomia, shoulder dystocia and pregnancy-induced hypertension, and are at higher risk of developing type 2 diabetes. Herein, we introduce a new conceptual term, "gestational prediabetes", which requires the absence of diabetes before pregnancy, and the presence of blood glucose levels (or a related marker) in early pregnancy that are higher than normal, but not yet high enough to meet the diagnostic criteria for GDM. Identifying women with gestational prediabetes might be done in early pregnancy (e.g., 12 weeks' gestation) using conventional glycaemic testing, assessment of visceral abdominal adiposity or hepatic fat by ultrasonography, or measuring serum sex hormone-binding globulin or adiponectin. However, none of these approaches has been systematically compared to conventional predictors, such as maternal body mass index or waist circumference. Any early-pregnancy predictor of gestational prediabetes risk needs to have low cost, ease of administration, and a short turnaround time. The theoretical advantage of identifying women with gestational prediabetes would be to "prevent" the onset of GDM (and its inherent risks to the pregnancy) in a timelier manner. One sensible starting point would be an intervention to prevent early excessive weight gain in pregnancy, which is currently being evaluated by two randomized clinical trials. In addition, early intervention could offset the need for resource-intense GDM management or insulin therapy.
- 1 September 2010
- Vol. 132, 251-5
Gestational prediabetes: a new term for early prevention?
Women with gestational diabetes mellitus (GDM) have higher rates of foetal macrosomia, shoulder dystocia and pregnancy-induced hypertension, and are at higher risk of developing type 2 diabetes. Herein, we introduce a new conceptual term, "gestational prediabetes", which requires the absence of diabetes before pregnancy, and the presence of blood glucose levels (or a related marker) in early pregnancy that are higher than normal, but not yet high enough to meet the diagnostic criteria for GDM. Identifying women with gestational prediabetes might be done in early pregnancy (e.g., 12 weeks' gestation) using conventional glycaemic testing, assessment of visceral abdominal adiposity or hepatic fat by ultrasonography, or measuring serum sex hormone-binding globulin or adiponectin. However, none of these approaches has been systematically compared to conventional predictors, such as maternal body mass index or waist circumference. Any early-pregnancy predictor of gestational prediabetes risk needs to have low cost, ease of administration, and a short turnaround time. The theoretical advantage of identifying women with gestational prediabetes would be to "prevent" the onset of GDM (and its inherent risks to the pregnancy) in a timelier manner. One sensible starting point would be an intervention to prevent early excessive weight gain in pregnancy, which is currently being evaluated by two randomized clinical trials. In addition, early intervention could offset the need for resource-intense GDM management or insulin therapy.
- 1 August 2010
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 56 (2) , 203-204
In reply
- Open Access
- 23 April 2009
- Published by American Diabetes Association in Diabetes Care
- Vol. 32 (7) , 1308-1310
Abdominal Visceral Adiposity in the First Trimester Predicts Glucose Intolerance in Later Pregnancy
OBJECTIVE: To assess whether abdominal adiposity in early pregnancy is associated with a higher risk of glucose intolerance at a later gestational stage. RESEARCH DESIGN AND METHODS: Subcutaneous and visceral fat was measured with ultrasonography at ∼12 weeks' gestation. A 50-g glucose challenge test (GCT) was performed between 24 and 28 weeks' gestation. The risk of having a positive GCT (≥7.8 mmol/l) was determined in association with subcutaneous and visceral adipose tissue depths above their respective upper-quartile values relative to their bottom three quartile values. RESULTS: Sixty-two women underwent GCTs. A visceral adipose tissue depth above the upper quartile value was significantly associated with a positive GCT in later pregnancy (adjusted odds ratio 16.9 [95% CI 1.5–194.6]). No associations were seen for subcutaneous adipose tissue. CONCLUSIONS: Measurement of visceral adipose tissue depth in early pregnancy may be associated with glucose intolerance later in pregnancy.
- 23 April 2009
- Published by American Diabetes Association in Diabetes Care
- Vol. 32 (7) , 1308-1310
Open AccessAbdominal Visceral Adiposity in the First Trimester Predicts Glucose Intolerance in Later Pregnancy
OBJECTIVE: To assess whether abdominal adiposity in early pregnancy is associated with a higher risk of glucose intolerance at a later gestational stage. RESEARCH DESIGN AND METHODS: Subcutaneous and visceral fat was measured with ultrasonography at ∼12 weeks' gestation. A 50-g glucose challenge test (GCT) was performed between 24 and 28 weeks' gestation. The risk of having a positive GCT (≥7.8 mmol/l) was determined in association with subcutaneous and visceral adipose tissue depths above their respective upper-quartile values relative to their bottom three quartile values. RESULTS: Sixty-two women underwent GCTs. A visceral adipose tissue depth above the upper quartile value was significantly associated with a positive GCT in later pregnancy (adjusted odds ratio 16.9 [95% CI 1.5–194.6]). No associations were seen for subcutaneous adipose tissue. CONCLUSIONS: Measurement of visceral adipose tissue depth in early pregnancy may be associated with glucose intolerance later in pregnancy.
- 1 September 2008
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 14 (5) , 369-373
Hyperhomocysteinemia: no longer a consideration in the management of venous thromboembolism
To determine whether clinicians should continue to screen for or treat hyperhomocysteinemia among individuals with venous thromboembolism. The present review addresses four questions: Is hyperhomocysteinemia a risk factor for venous thromboembolism? Are the genetic polymorphisms that cause hyperhomocysteinemia risk factors for venous thromboembolism? Does lowering plasma homocysteine alter the risk of venous thromboembolism? What should clinicians do? There may be a modest association between mild-to-moderate hyperhomocysteinemia and venous thromboembolism risk. This may be partly explained by genetic polymorphisms that affect homocysteine metabolism. However, two randomized placebo-controlled trials have failed to show a significant reduction in the risk of venous thromboembolism by lowering plasma homocysteine.
- 1 September 2008
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 14 (5) , 369-373
Hyperhomocysteinemia: no longer a consideration in the management of venous thromboembolism
To determine whether clinicians should continue to screen for or treat hyperhomocysteinemia among individuals with venous thromboembolism. The present review addresses four questions: Is hyperhomocysteinemia a risk factor for venous thromboembolism? Are the genetic polymorphisms that cause hyperhomocysteinemia risk factors for venous thromboembolism? Does lowering plasma homocysteine alter the risk of venous thromboembolism? What should clinicians do? There may be a modest association between mild-to-moderate hyperhomocysteinemia and venous thromboembolism risk. This may be partly explained by genetic polymorphisms that affect homocysteine metabolism. However, two randomized placebo-controlled trials have failed to show a significant reduction in the risk of venous thromboembolism by lowering plasma homocysteine.
- Open Access
- 22 June 2008
- Published by SAGE Publications in Food and Nutrition Bulletin
- Vol. 29 (2_suppl1) , S225-S230
Efficacy of Canadian Folic Acid Food Fortification
Canada mandated that cereal grains, especially white flour, be fortified with folic acid by mid-1998. Between 0.1 and 0.2 mg of additional synthetic folic acid per day has been provided through this initiative. The current paper describes how this took place, and the epidemiological effects that occurred in the Canadian population, including higher blood folate levels and a decline in the prevalence of neural tube defects.
- 22 June 2008
- Published by SAGE Publications in Food and Nutrition Bulletin
- Vol. 29 (2_suppl1) , S225-S230
Open AccessEfficacy of Canadian Folic Acid Food Fortification
Canada mandated that cereal grains, especially white flour, be fortified with folic acid by mid-1998. Between 0.1 and 0.2 mg of additional synthetic folic acid per day has been provided through this initiative. The current paper describes how this took place, and the epidemiological effects that occurred in the Canadian population, including higher blood folate levels and a decline in the prevalence of neural tube defects.
- Open Access
- 13 May 2008
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 5 (5) , e104
Alcohol Sales and Risk of Serious Assault
Alcohol is a contributing cause of unintentional injuries, such as motor vehicle crashes. Prior research on the association between alcohol use and violent injury was limited to survey-based data, and the inclusion of cases from a single trauma centre, without adequate controls. Beyond these limitations was the inability of prior researchers to comprehensively capture most alcohol sales. In Ontario, most alcohol is sold through retail outlets run by the provincial government, and hospitals are financed under a provincial health care system. We assessed the risk of being hospitalized due to assault in association with retail alcohol sales across Ontario. We performed a population-based case-crossover analysis of all persons aged 13 years and older hospitalized for assault in Ontario from 1 April 2002 to 1 December 2004. On the day prior to each assault case's hospitalization, the volume of alcohol sold at the store in closest proximity to the victim's home was compared to the volume of alcohol sold at the same store 7 d earlier. Conditional logistic regression analysis was used to determine the associated relative risk (RR) of assault per 1,000 l higher daily sales of alcohol. Of the 3,212 persons admitted to hospital for assault, nearly 25% were between the ages of 13 and 20 y, and 83% were male. A total of 1,150 assaults (36%) involved the use of a sharp or blunt weapon, and 1,532 (48%) arose during an unarmed brawl or fight. For every 1,000 l more of alcohol sold per store per day, the relative risk of being hospitalized for assault was 1.13 (95% confidence interval [CI] 1.02–1.26). The risk was accentuated for males (1.18, 95% CI 1.05–1.33), youth aged 13 to 20 y (1.21, 95% CI 0.99–1.46), and those in urban areas (1.19, 95% CI 1.06–1.35). The risk of being a victim of serious assault increases with alcohol sales, especially among young urban men. Akin to reducing the risk of driving while impaired, consideration should be given to novel methods of preventing alcohol-related violence.
- 13 May 2008
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 5 (5) , e104
Open AccessAlcohol Sales and Risk of Serious Assault
Alcohol is a contributing cause of unintentional injuries, such as motor vehicle crashes. Prior research on the association between alcohol use and violent injury was limited to survey-based data, and the inclusion of cases from a single trauma centre, without adequate controls. Beyond these limitations was the inability of prior researchers to comprehensively capture most alcohol sales. In Ontario, most alcohol is sold through retail outlets run by the provincial government, and hospitals are financed under a provincial health care system. We assessed the risk of being hospitalized due to assault in association with retail alcohol sales across Ontario. We performed a population-based case-crossover analysis of all persons aged 13 years and older hospitalized for assault in Ontario from 1 April 2002 to 1 December 2004. On the day prior to each assault case's hospitalization, the volume of alcohol sold at the store in closest proximity to the victim's home was compared to the volume of alcohol sold at the same store 7 d earlier. Conditional logistic regression analysis was used to determine the associated relative risk (RR) of assault per 1,000 l higher daily sales of alcohol. Of the 3,212 persons admitted to hospital for assault, nearly 25% were between the ages of 13 and 20 y, and 83% were male. A total of 1,150 assaults (36%) involved the use of a sharp or blunt weapon, and 1,532 (48%) arose during an unarmed brawl or fight. For every 1,000 l more of alcohol sold per store per day, the relative risk of being hospitalized for assault was 1.13 (95% confidence interval [CI] 1.02–1.26). The risk was accentuated for males (1.18, 95% CI 1.05–1.33), youth aged 13 to 20 y (1.21, 95% CI 0.99–1.46), and those in urban areas (1.19, 95% CI 1.06–1.35). The risk of being a victim of serious assault increases with alcohol sales, especially among young urban men. Akin to reducing the risk of driving while impaired, consideration should be given to novel methods of preventing alcohol-related violence.
- 1 May 2008
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 126 (5) , 692-699
Retinal Vein Occlusion and Traditional Risk Factors for Atherosclerosis
Research from JAMA Ophthalmology — Retinal Vein Occlusion and Traditional Risk Factors for Atherosclerosis
- 1 May 2008
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 126 (5) , 692-699
Retinal Vein Occlusion and Traditional Risk Factors for Atherosclerosis
Research from JAMA Ophthalmology — Retinal Vein Occlusion and Traditional Risk Factors for Atherosclerosis
- Open Access
- 21 January 2008
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 101 (6) , 475-477
High rate of maternal vitamin B12 deficiency nearly a decade after Canadian folic acid flour fortification
Vitamin B12 deficiency may be an independent risk factor for neural tube defects (NTD). We determined the prevalence of biochemical B12 deficiency (<125 pmol/l) among 10 622 Ontarian women aged 15–46 years who underwent concomitant testing of serum bhCG and B12 9 years after the implementation of Canadian folic acid flour fortification. The overall prevalence of biochemical B12 deficiency was 7.4%. Relative to non-pregnant women, the adjusted odds ratio (95% confidence interval) of biochemical B12 deficiency was 0.78 (0.60–1.0) among women pregnant 28 days gestation or less and was 1.4 (1.1–1.8) after 28 days gestation. About 1 in 20 women may be deficient in B12 in early pregnancy. The impact on maternal and fetal well-being, including preventable NTD, should be considered.
- 21 January 2008
- Published by Oxford University Press (OUP) in QJM: An International Journal of Medicine
- Vol. 101 (6) , 475-477
Open AccessHigh rate of maternal vitamin B12 deficiency nearly a decade after Canadian folic acid flour fortification
Vitamin B12 deficiency may be an independent risk factor for neural tube defects (NTD). We determined the prevalence of biochemical B12 deficiency (<125 pmol/l) among 10 622 Ontarian women aged 15–46 years who underwent concomitant testing of serum bhCG and B12 9 years after the implementation of Canadian folic acid flour fortification. The overall prevalence of biochemical B12 deficiency was 7.4%. Relative to non-pregnant women, the adjusted odds ratio (95% confidence interval) of biochemical B12 deficiency was 0.78 (0.60–1.0) among women pregnant 28 days gestation or less and was 1.4 (1.1–1.8) after 28 days gestation. About 1 in 20 women may be deficient in B12 in early pregnancy. The impact on maternal and fetal well-being, including preventable NTD, should be considered.